Single-cell analysis (SCA) in recent years has emerged as a powerful framework for characterizing cellular heterogeneity and dynamic biological processes. The analytical potential of SCA has been enhanced by recent technological advances in microfluidics, next-generation sequencing, and high-sensitivity detection platforms. Complementary to single-cell RNA sequencing (scRNA-seq) and its integrative modalities such as CITE-seq and REAP-seq, which enable simultaneous profiling of the transcriptome and proteome, single-cell multiomics can incorporate genomic, epigenomic, and other omics data to construct an integrated cellular landscape. Third-generation long-read technology, such as nanopore sequencing, allow amplification-free analysis of DNA and RNA, enabling the identification of full-length isoforms, structural variations, and epigenetic modifications at the single-cell level. Additionally, advanced imaging methods such as stimulated emission depletion (STED) microscopy and quantum-enhanced single-cell nuclear magnetic resonance (NMR) spectroscopy provide noninvasive and spatially resolved molecular characterization. The emerging trends in SCA with novel approaches like combinatorial indexing, AI-based data integration, and spatial transcriptomics are transitioning SCA from a descriptive science to one that provides predictive insights and clinical implications. Despite ongoing limitations related to data quality, cost, and computational complexity of SCA and although data quality, high cost, and computational complexity are huge challenges of SCA, these emerging technologies collectively advance precision medicine, disease modeling, and drug discovery through improved understanding of cellular function and diversity.